Perfluorodecalin emulsion tested for biocompatibility in macrophages by means of a magnetometric method

M Koester1, J Lutz, A J Augustin

  • 1Dept. of Physiology, University of Wuerzburg, Germany.

Insights

A novel perfluorodecalin (FDC) emulsion and first-generation perfluorochemical (PFC) emulsion were tested for their effects on rat Kupffer cells. Higher doses of both emulsions temporarily reduced Kupffer cell activity, with FDC showing a shorter duration of effect.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Toxicology

Background:

  • Perfluorochemical (PFC) emulsions are used in biomedical applications, including as blood substitutes.
  • Kupffer cells are resident macrophages in the liver, playing a crucial role in immune responses.
  • Understanding the in vivo effects of novel PFC emulsions on immune cells is vital for assessing their safety and efficacy.

Purpose of the Study:

  • To evaluate the influence of a stable perfluorodecalin (FDC) emulsion on rat Kupffer cells in vivo.
  • To compare the effects of FDC emulsion with a first-generation PFC emulsion (Fluosol-DA, FDA).
  • To assess the dose-dependent and time-dependent effects of these emulsions on Kupffer cell intracellular motility.

Main Methods:

  • A magnetometric procedure was employed to assess Kupffer cell activity in rats.
  • Rats were administered varying doses (0.1 g/kg, 1 g/kg, 3 g/kg body weight) of FDC and FDA emulsions.
  • Intracellular movements of Kupffer cells were measured at different time points post-administration.

Main Results:

  • Low doses (0.1 g/kg) of both FDC and FDA caused a minor increase in Kupffer cell activity.
  • Higher doses (1 g/kg) led to a significant retardation of intracellular movements for 2 days (FDC) and 4 days (FDA).
  • A high dose (3 g/kg) of FDC significantly depressed Kupffer cell activity for 8 days, while FDA caused depression for 32 days.

Conclusions:

  • Both FDC and FDA emulsions can modulate Kupffer cell activity in a dose-dependent manner.
  • The FDC emulsion demonstrated a less prolonged effect on Kupffer cell intracellular motility compared to FDA at higher doses.
  • These findings suggest differential immunomodulatory effects of PFC emulsions, impacting their potential clinical applications.

Related Concept Videos